5-HT1A RECEPTOR FULL AND PARTIAL AGONISTS AND 5-HT2C (BUT NOT 5-HT3) RECEPTOR ANTAGONISTS INCREASE RATES OF PUNISHED RESPONDING IN RATS

被引:25
作者
CERVO, L [1 ]
SAMANIN, R [1 ]
机构
[1] IST RIC FARMACOL MARIO NEGRI,I-20157 MILAN,ITALY
关键词
5-HT2C RECEPTORS; 5-HT3; RECEPTORS; BENZODIAZEPINES; OPERANT CONFLICT; ANXIOLYTIC ACTIVITY; PUNISHMENT;
D O I
10.1016/0091-3057(95)00189-4
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Drugs with different intrinsic activity at 5-HT1A receptors and antagonists at 5-HT2A/2C and 5-HT3 receptors were studied for their ability to increase the rates of punished operant responding in rats. Like chlordiazepoxide (5 and 10 mg/kg) and diazepam (1.25 and 2.5 mg/kg), 0.125 mg/kg 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a 5-HT1A receptor agonist, and 5 and 10 mg/kg ipsapirone, a partial agonist at these receptors, increased the rates of punished responding, whereas (8)-WAY 100135, a 5-HT1A receptor antagonist, had no effect at doses from 1 to 10 mg/kg. 8-OH-DPAT and ipsapirone, like benzodiazepines, significantly reduced unpunished responding. The 5-HT2A/2C receptor antagonists ritanserin (2 mg/kg), mianserin (8 mg/kg), and mesulergine (0.1 mg/kg) significantly increased the rates of punished responding, whereas 0.5-2 mg/kg ketanserin, that has higher affinity for 5-HT2A than 5-HT2C receptors, had no effect. Antagonists, at 5-HT3 receptors such as ondansetron (0.001-0.1 mg/kg) and tropisetron (0.001-0.1 mg/kg), had no effect on punished or unpunished responding. The results show that agents acting as full or partial agonists at 5-HT1A receptors and blockers of postsynaptic 5-HT2C receptors have anxiolytic-like effects in a model of punished operant responding, whereas antagonists at 5-HT1A and 5-HT3 receptors have no such effect.
引用
收藏
页码:671 / 676
页数:6
相关论文
共 40 条
[1]  
ANDRADE R, 1987, N-S ARCH PHARMACOL, V336, P5
[2]   BEHAVIORAL PHARMACOLOGY OF 5-HT3-RECEPTOR LIGANDS [J].
BARNES, JM ;
BARNES, NM ;
COOPER, SJ .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1992, 16 (01) :107-113
[3]   5-HT RECEPTORS AS TARGETS FOR THE DEVELOPMENT OF NOVEL ANXIOLYTIC DRUGS - MODELS, MECHANISMS AND FUTURE-DIRECTIONS [J].
BARRETT, JE ;
VANOVER, KE .
PSYCHOPHARMACOLOGY, 1993, 112 (01) :1-12
[4]  
BRILEY M, 1991, 5 HYDROXYTRYPTAMINE, P177
[5]   PHARMACOLOGICAL PROPERTIES OF GR38032F, A NOVEL ANTAGONIST AT 5-HT3 RECEPTORS [J].
BUTLER, A ;
HILL, JM ;
IRELAND, SJ ;
JORDAN, CC ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 94 (02) :397-412
[6]   EVIDENCE THAT CENTRAL 5-HYDROXYTRYPTAMINERGIC NEURONS ARE INVOLVED IN THE ANXIOLYTIC ACTIVITY OF BUSPIRONE [J].
CARLI, M ;
PRONTERA, C ;
SAMANIN, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (04) :829-836
[7]   POTENTIAL ANXIOLYTIC PROPERTIES OF 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN, A SELECTIVE SEROTONIN1A RECEPTOR AGONIST [J].
CARLI, M ;
SAMANIN, R .
PSYCHOPHARMACOLOGY, 1988, 94 (01) :84-91
[8]  
CERVO L, 1995, IN PRESS EUR J PHARM
[9]   THE INFLUENCE OF RITANSERIN, A SEROTONIN ANTAGONIST, IN ANXIETY DISORDERS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY VERSUS LORAZEPAM [J].
CEULEMANS, DLS ;
HOPPENBROUWERS, MLJA ;
GELDERS, YG ;
REYNTJENS, AJM .
PHARMACOPSYCHIATRY, 1985, 18 (05) :303-305
[10]   EFFECTS OF 5-HT1A RECEPTOR LIGANDS ON A SAFETY SIGNAL WITHDRAWAL PROCEDURE OF CONFLICT IN THE RAT [J].
CHARRIER, D ;
DANGOUMAU, L ;
HAMON, M ;
PUECH, AJ ;
THIEBOT, MH .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 48 (01) :281-289